CTNND1 and head and neck squamous cell carcinoma: Given that p120ctn can alter EGFR therapy in HNSCC [10] and, as shown in Fig 1, p120ctn is downregulated following DBPDE treatment, we set out to determine if BRB treatment altered p120ctn expression in DBPDE-induced tumors.